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BACKGROUND: Stereotactic brain biopsy is among the most common neurosurgical
procedures. Planning an optimally safe surgical trajectory requires careful attention to a
number of features including the following: (1) traversing the skull perpendicularly; (2)
minimizing trajectory length; and (3) avoiding critical neurovascular structures.
OBJECTIVE: To evaluate a platform, SurgiNav, for automated trajectory planning in stereo-
tactic brain biopsy.
METHODS: A prospectively maintained database was searched between February and
August 2017 to identify all adult patients who underwent stereotactic brain biopsy and
for whom postoperative imaging was available. In each case, the standard preoperative,
T1-weighted, gadolinium-enhanced magnetic resonance imaging was used to generate
a model of the cortex. A surgical trajectory was then generated using computer-assisted
planning (CAP) , andmetrics of the trajectorywere compared to the trajectory of the previ-
ously implemented manual plan (MP).
RESULTS: Fifteen consecutive patients were identified. Feasible trajectories were
generated using CAP in all patients, and the mean angle determined using CAP was more
perpendicular to the skull than usingMP (10.0◦ vs 14.6◦ fromorthogonal; P= .07), themean
trajectory length was shorter (38.5 vs 43.5 mm; P = .01), and the risk score was lower (0.27
vs 0.52; P = .03).
CONCLUSION: CAP for stereotactic brain biopsy appears feasible and may be safer in
selected cases.
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S tereotactic brain biopsy is among themost common neurosurgical procedures.The principles of stereotactic surgery were
introduced by Horsley and Clarke1 over a
century ago to explore the primate brain, and
brought into surgical practice by Spiegel et al.2
With the introduction of computed tomog-
raphy (CT) in the 1970s andmagnetic resonance
imaging (MRI) in the 1980s, stereotactic biopsy
has become increasingly widespread. Indications
ABBREVIATIONS: CAP, computer-assisted plan; CT,
computed tomography; DBS, deep brain stimu-
lation; MP, manual plan; MR, magnetic resonance;
MRI, magnetic resonance imaging; SEEG, stere-
oelectroencephalography; STROBE, Strengthening
the Reporting of Observational Studies in Epidemi-
ology
for stereotactic biopsy include brain lesions that
are deep seated, present in eloquent areas, or
located at multiple sites, for which there remains
diagnostic uncertainty. Stereotactic biopsy is safe
and effective in most cases, with a recent large
series finding a diagnostic yield of 98.2%, a
morbidity rate of 8.5%, and a mortality rate of
0.6%.3
Planning an optimal trajectory for stereo-
tactic brain biopsy requires careful attention to
a number of features, including the following:
(1) traversing the skull perpendicularly; (2)
minimizing trajectory length; and (3) avoiding
critical neurovascular structures. In cases such as
brainstem biopsy, which necessitates proximity
to numerous critical neurovascular structures
over a long length, planning a safe surgical
trajectory can be particularly challenging and
time-consuming.
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Current commercially available software allows the surgeon to
select the target lesion and an entry point, resulting in the gener-
ation of a manually planned trajectory. The surgeon may then
review the trajectory in the axial, coronal, and sagittal planes and
can also do so with a “probe’s eye,” which offers a look-ahead view.
A degree of trial and error is usually necessary to ensure an optimal
trajectory.
Computer assistance may theoretically allow for safer and
more straightforward surgical trajectory planning. Our group has
previously reported the successful use of a software platform,
EpiNavTM (research software not commercially available; UCL,
London, United Kingdom), in stereoelectroencephalography
(SEEG) and laser interstitial thermal therapy.4-7 To this end, the
aim of this study was to evaluate a related software platform,
SurgiNav (research software not commercially available; UCL,
London, United Kingdom), for computer-assisted planning in
stereotactic brain biopsy.
METHODS
A retrospective comparative pilot study design was adopted according
to the IDEAL-D model (stage 0) for safe surgical innovation8; the
SurgiNav software was used to generate computer-assisted plans
(CAPs) retrospectively, and these were compared to the actually imple-
mented manual plans (MPs) to determine feasibility and safety. The
Strengthening the Reporting of Observational Studies in Epidemiology
(STROBE) statement was used in the preparation of this section of the
manuscript.9
The study was registered as a Service Evaluation study with the
University College London Hospitals NHS Foundation Trust Clinical
Audit Committee (NHNN2018050). Informed consent was not sought,
as this was a retrospective study.
Setting and Participants
The study was conducted at a university hospital that acts as a regional
referral center for brain tumors.
All cases were recorded on a prospectively maintained database. The
database was searched over a 6-mo period between February 1 and August
1, 2017, to identify all adult patients who had undergone stereotactic
brain biopsy and for whom postoperative imaging was available, and,
subsequently, the implemented MP was derived.
Manual Plans
The MPs of surgical trajectories that were actually implemented
were generated using a Stealth platform (Medtronic) by one of the
senior neurosurgeons (N.K., A.W.M., A.M., and L.T.). In each case, the
preoperative, volumetric, T1-weighted, gadolinium-enhanced magnetic
resonance imaging (MRI) scan was used to identify the lesion(s). Entry
and target points were placed using the axial, coronal, and sagittal planes,
and the trajectory was checked using the probe’s eye reconstruction.
Computer-Assisted Plans
The CAPs of surgical trajectories were retrospectively generated using
the SurgiNav platform by one of the neurosurgeons involved in the
development of the platform (H.J.M. and V.V.). The technical aspects
of the CAP algorithm have been described previously.4-7 In brief, the
preoperative, volumetric, T1-weighted, gadolinium-enhanced MRI scan
was used to create a skull model and perform whole-brain parcellation,
which was then thresholded to create a cortical, gray matter, and sulcal
model.4-7 A target lesion was segmented, and a maximum angle (30.0◦
from orthogonal) and length (100mm) were defined by the surgeon. The
CAP algorithm then calculated entry and target points and ranked these
according to the risk score.
The risk score has previously been described as a function of the
cumulative distance from vessels along the whole trajectory.6 In this
study, we used sulci as the critical structure to avoid instead of the blood
vessels because of the variable quality of the images available to segment
the intracerebral vasculature. The risk score for a trajectory ranges from
0 (lowest risk) to 2 (highest risk): a risk score of 0 means the trajectory is
always at least 10 mm away from the nearest sulcus; a risk score between
0 and 2 is the cumulative sum of how close the trajectory is to the nearest
sulcus; and a risk score of 2 means the trajectory conflicts with a sulcus.
The 5 trajectories with the lowest risk were reviewed by the neurosurgeon,
and the most feasible one was chosen (Figure 1); this methodology has
been adopted in previous studies to account for surgeon preference and
to improve the feasibility of CAP trajectories.5
Outcomes
Data were collected on the metrics of CAP and MP trajectories,
diagnostic yield, morbidity, and mortality rates. Specimens were sent for
histopathological analysis and considered positive if they resulted in a
diagnosis. Immediate surgical complications were recorded according to
the Clavien-Dindo classification.10,11
The primary outcomes of this comparative study were as follows: (1)
trajectory angle from orthogonal; (2) trajectory length; and (3) risk score.
Study Size and Statistical Methods
No formal power calculation was performed, as data on the primary
outcomes were not available. Instead, the sample size was determined
through adopting a constraint-based pragmatic approach and based on
previous related studies.12 We considered a minimum of 12 patients in
each group sufficient for a meaningful analysis in this pilot study, and it
was estimated that this would be achieved over a 6-mo period.
Data were analyzed using SPSS v 20.0 (IBM, Chicago, Illinois). We
have previously shown that trajectory metrics are normally distributed.5
The mean and standard deviations were calculated. Data were compared
using the paired t-test, with a value of P < .05 considered statistically
significant.
RESULTS
Participants and Descriptive Data
Fifteen consecutive patients were identified who had
undergone stereotactic brain biopsy using MP surgical trajec-
tories between February 1 and August 1, 2017, and for whom
postoperative imaging was available. The patient demographics
are detailed in Table 1. Their median age was 62 yr (range: 18-78
yr), and the male-to-female ratio was 4:1. Brain lesions were most
commonly located in the frontal and parietal regions (8/15).
Outcome Data andMain Results
All patients had a diagnostic biopsy, and the patient pathologies
are detailed in Table 1. The most common pathology was
glioblastoma multiforme (13/15). There were no immediate
2 | VOLUME 0 | NUMBER 0 | 2019 www.operativeneurosurgery-online.com
D
ow
nloaded from
 https://academ
ic.oup.com
/ons/advance-article-abstract/doi/10.1093/ons/opz177/5543970 by U
niversity C
ollege London user on 12 August 2019
COMPUTER-ASSISTED BRAIN BIOPSY
FIGURE 1. SurgiNav was used to generate a computer-assisted trajectory in a patient with a pineal region lesion. The left panel demonstrates the axial, coronal, and
sagittal planes with the CAP trajectory in yellow. The right panel provides the trajectory metrics and allows the surgeon to cycle between CAP trajectories.
TABLE 1. Patient Demographics and Pathology
Case Age (yr) Sex (M/F) Location Pathology
1 70 F Left parietal GBM
2 62 F Right parietal GBM
3 66 M Left frontal GBM
4 78 M Left frontal GBM
5 62 M Right frontal GBM
6 54 M Pineal region GBM
7 72 M Right occipital GBM
8 72 M Corpus callosum GBM
9 56 M Right parietal GBM
10 44 F Left frontal GBM
11 64 M Left temporal GBM
12 46 M Corpus callosum Multifocal
germinoma
13 18 M Left temporal Pilocytic
astrocytoma
14 60 M Left thalamic GBM
15 57 M Right parietal GBM
M=male, F= female, GBM= glioblastoma multiforme.
TABLE 2. Trajectory Angle From Orthogonal (◦), Trajectory Length
(mm), and Risk Score in MPs and CAPs
MP CAP
Case Angle (◦) Length (mm) Risk Angle (◦) Length (mm) Risk
1 9.6 35.0 0.18 7.8 35.5 0.02
2 15.4 49.6 0.00 0.5 44.8 0.00
3 16.3 42.4 1.21 10.6 49.4 1.03
4 25.5 30.1 0.00 4.1 17.0 0.00
5 15.0 39.4 0.00 9.0 27.0 0.00
6 18.9 95.4 1.09 20.7 94.6 1.16
7 30.1 17.5 0.00 9.3 16.6 0.00
8 2.2 46.8 1.16 9.2 41.2 0.00
9 11.0 29.1 0.00 4.2 14.1 0.00
10 18.2 28.8 0.00 14.8 15.1 0.00
11 5.4 39.9 1.03 14.4 39.3 0.37
12 20.9 55.6 1.15 14.6 49.9 0.13
13 9.0 47.3 0.00 1.2 45.1 0.00
14 7.9 64.1 1.03 16.5 57.6 1.04
15 14.2 31.6 1.00 12.7 31.0 0.32
CAP = computer-assisted plan, MP= manual plan.
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FIGURE 2. SurgiNav was used to compare CAP (blue) and MP (red) trajectories in a patient with a left frontal lesion. Note that whereas a T1-weighted, gadolinium-
enhanced MRI was used to generate a model of the cortex, a T2-weighted MRI has been used in this figure to better illustrate the lesion.
surgical complications. The median length of postoperative
inpatient stay was 4 d (range: 1-38 d).
The primary outcomes are detailed in Table 2. Feasible trajec-
tories were generated using CAP in all patients. In case 6, the
target lesion was located within the pineal region and the entry
region was constrained to the right frontal lobe.
An illustrative case comparing CAP and MP trajectories is
shown in Figure 2. The mean angle using CAP was more
perpendicular to the skull than using MP (10.0◦ vs 14.6◦ from
orthogonal; P = .07), the mean trajectory length was shorter
(38.5 vs 43.5 mm; P = .01), and the risk score was lower (0.27
vs 0.52; P = .03) (Figure 3).
DISCUSSION
Principal Findings
We found that CAP for stereotactic brain biopsy appears
feasible and may be safer than MP in selected cases. The
SurgiNav platform was able to generate feasible trajectories
in all cases, the CAP trajectories were significantly shorter,
and the risk scores were lower than those of MP trajectories.
These findings are promising and merit stage 1 and 2 clinical
trials in accordance with the IDEAL-D model for safe surgical
innovation.8
ComparisonWith Other Studies
This is the first study that describes CAP for surgical trajectory
planning in stereotactic brain biopsy. CAP has been used in
neurosurgery for over 30 yr,13 and the successful use of CAP
for surgical trajectory planning has been described for deep
brain stimulation (DBS),12,14 SEEG,4-6,15 and laser trajectory
planning.7
Beriault et al12 developed a platform for CAP in DBS.
Their trajectory planning algorithm analyzed every trajectory
connecting the ipsilateral frontal lobe to a surgeon-defined target
point using a 2-pass technique. In the first pass, trajectories
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FIGURE 3. Graphs comparing MPs and CAPs: A, mean trajectory angle from
orthogonal (◦);B, mean trajectory length (mm); andC, mean risk score. ∗P< .05.
that traversed the ventricles or were too close to sulci were
eliminated. In the second pass, the remaining trajectories
were ranked according to their distance from all critical struc-
tures. In a retrospective comparative study of 14 patients
who had undergone DBS for Parkinson disease, feasible
trajectories were generated in all cases, and the CAP trajec-
tories appeared to have favorable risk metrics compared to the
implemented MP trajectories, although no statistical analysis
was performed.
De Momi et al15 developed a platform for CAP in SEEG.
Their trajectory planning algorithm analyzed every trajectory
connecting approximate surgeon-defined entry and target points
and ranked these according to their distance from critical struc-
tures and the drilling angle. In a retrospective analysis of 26
electrodes in 3 patients undergoing SEEG, a feasible trajectory
was generated in 86% of cases, and the CAP trajectories resulted
in a significantly greater distance from vessels compared to that of
the implemented MP trajectories.
Our group has previously reported the successful use of a
software platform, EpiNavTM, in SEEG.4-6 In an initial study
of 166 electrodes in 18 patients undergoing SEEG, a feasible
trajectory was generated in 79% of cases, and the CAP trajec-
tories resulted in a significantly reduced risk score compared to
that of the implemented MP trajectories.4 In a subsequent study
of 116 electrodes in 13 patients undergoing SEEG, we improved
the algorithm.5 Rather than a single surgeon-defined target point,
an entire anatomical structure could be selected based on whole-
brain parcellation, allowing the algorithm to select the safest target
within the anatomical structure of interest.
EpiNavTM has most recently been applied to laser interstitial
thermal therapy. In a retrospective study of 25 patients who
underwent laser interstitial thermal therapy for mesial temporal
lobe epilepsy, a feasible trajectory was generated in all cases. The
mean risk score obtained using CAP was lower than that obtained
using MP, and the trajectory length was shorter. Furthermore,
CAP trajectories would have resulted in a greater ablation of the
amygdala and amygdalohippocampal complex.
In this study, the application of SurgiNav to stereotactic brain
biopsy had constraints when compared to the previous use
of EpiNavTM for SEEG and laser interstitial thermal therapy.
Patients undergoing surgery for epilepsy routinely undergo
extensive MRI, including MR angiography and venography,
whereas patients undergoing stereotactic brain biopsy in our insti-
tution routinely undergo volumetric, T1-weighted, gadolinium-
enhanced MRI alone so that a reliable segmentation of blood
vessels is not possible. In consequence, we used sulci as the critical
structure to avoid instead of the blood vessels themselves.
Several studies have described multimodal imaging in stereo-
tactic brain biopsy, and it has been suggested that selecting targets
within regions of high relative cerebral blood flow or specific
signatures onMR spectroscopy may improve biopsy yield.16,17 In
the future, we will combine the use of such multimodal imaging
with SurgiNav to improve the safety and efficacy of stereotactic
brain biopsy.
Limitations
As noted, we used sulci as the critical structure to avoid instead
of blood vessels themselves because of the variable quality of the
vascular imaging. The risk of hemorrhage is significantly greater
when trajectories traverse sulci.18 As the risk score was the primary
optimization criterion for CAP, using this score to compare CAP
and MP trajectories inevitably resulted in bias toward CAP. In
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future studies, we will assess how well the risk score predicts
complications in patients undergoing stereotactic brain biopsy,
but, at present, we are unable to extrapolate the relative risk
reduction of hemorrhage.
The time required to generate CAP and MP trajectories was
not recorded in this retrospective study. Although SurgiNav was
able to calculate entry and target points in a few minutes, the
prerequisite whole-brain parcellation took up to an hour, albeit on
a workstation without surgeon intervention over this time. This
represents a potential drawback to the clinical use of SurgiNav
in stereotactic brain biopsy, which, unlike SEEG or laser inter-
stitial thermal therapy, is often undertaken as a matter of clinical
urgency.Wewill optimize the whole-brain parcellation algorithm,
and take advantage of the increasing computing power, to reduce
the time taken.
The small and retrospective nature of this study has the
potential for bias. Nonetheless, the findings encourage larger
prospective clinical studies.
CONCLUSION
CAP for stereotactic brain biopsy appears feasible and may be
safer in selected cases. The findings of this retrospective compar-
ative pilot study merit further development of the SurgiNav
platform and stage 1 and 2 clinical trials in accordance with the
IDEAL-D model for safe surgical innovation.
Disclosures
This publication represents, in part, an independent research commissioned
by the Health Innovation Challenge Fund (HICF-T4-275, WT097914, and
WT106882), a parallel funding partnership between the Wellcome Trust and
the Department of Health, and the National Institute for Health Research
University College London Hospitals Biomedical Research Centre (NIHR BRC
UCLH/UCL High Impact Initiative). The authors have no personal, financial,
or institutional interest in any of the drugs, materials, or devices described in this
article.
REFERENCES
1. Horsley V, Clarke RH. The structure and functions of the cerebellum examined
by a new method. Brain. 1908;31(1):45-124.
2. Spiegel EA, Wycis HT, Marks M, Lee AJ. Stereotaxic apparatus for operations
on the human brain. Science. 1947;106(2754):349-350.
3. Dammers R, Schouten JW, Haitsma IK, Vincent AJ, Kros JM, Dirven CM.
Towards improving the safety and diagnostic yield of stereotactic biopsy in a single
centre. Acta Neurochir. 2010;152(11):1915-1921.
4. Nowell M, Sparks R, Zombori G, et al. Comparison of computer-assisted
planning and manual planning for depth electrode implantations in epilepsy. J
Neurosurg. 2016;124(6):1820-1828.
5. Vakharia VN, Sparks R, Rodionov R, et al. Computer-assisted planning for
the insertion of stereoelectroencephalography electrodes for the investigation of
drug-resistant focal epilepsy: an external validation study. J Neurosurg. 2018:1-10.
published online: April 1, 2018 (doi:10.3171/2017.10.JNS171826).
6. Sparks R, Vakharia V, Rodionov R, et al. Anatomy-driven multiple trajectory
planning (ADMTP) of intracranial electrodes for epilepsy surgery. Int J Comput
Assist Radiol Surg. 2017;12(8):1245-1255.
7. Vakharia VN, Sparks R, Li K, et al. Automated trajectory planning for laser inter-
stitial thermal therapy in mesial temporal lobe epilepsy. Epilepsia. 2018;59(4):814-
824.
8. Sedrakyan A, Campbell B,Merino JG, Kuntz R, Hirst A,McCulloch P. IDEAL-
D: a rational framework for evaluating and regulating the use of medical devices.
BMJ. 2016;353:i2372.
9. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke
JP. The Strengthening the Reporting of Observational Studies in Epidemiology
(STROBE) statement: guidelines for reporting observational studies. Lancet North
Am Ed. 2007;370(9596):1453-1457.
10. Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo classification of
surgical complications. Ann Surg. 2009;250(2):187-196.
11. Dindo D, Demartines N, Clavien PA. Classification of surgical complications.
Ann Surg. 2004;240(2):205-213.
12. Beriault S, Subaie FA, Collins DL, Sadikot AF, Pike GB. A multi-modal
approach to computer-assisted deep brain stimulation trajectory planning. Int J
Comput Assist Radiol Surg. 2012;7(5):687-704.
13. Davis DH, Kelly PJ, Marsh WR, Kall BA, Goerss SJ. Computer-assisted
stereotactic biopsy of intracranial lesions in pediatric patients. Pediatr Neurosurg.
1988;14(1):31-36.
14. Essert C, Haegelen C, Lalys F, Abadie A, Jannin P. Automatic computation of
electrode trajectories for deep brain stimulation: a hybrid symbolic and numerical
approach. Int J Comput Assist Radiol Surg. 2012;7(4):517-532.
15. De Momi E, Caborni C, Cardinale F, et al. Multi-trajectories automatic
planner for stereoelectroencephalography (SEEG). Int J Comput Assist Radiol
Surg. 2014;9(6):1087-1097.
16. Verburg N, Hoefnagels F, Pouwels P, et al. The diagnostic accuracy of neuro-
imaging to detect infiltrative glioma within the brain: a meta-analysis based on
1598 patients in 58 publications. Neuro-Oncology. 2013;15(suppl 3):iii191-iii205.
http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed12&
NEWS=N&AN=71299671.
17. Bulik M, Jancalek R, Vanicek J, Skoch A,Mechl M. Potential ofMR spectroscopy
for assessment of glioma grading. Clin Neurol Neurosurg. 2013;115(2):146-
153.
18. Elias WJ, Sansur CA, Frysinger RC. Sulcal and ventricular trajectories in stereo-
tactic surgery. J Neurosurg. 2009;110(2):201-207.
6 | VOLUME 0 | NUMBER 0 | 2019 www.operativeneurosurgery-online.com
D
ow
nloaded from
 https://academ
ic.oup.com
/ons/advance-article-abstract/doi/10.1093/ons/opz177/5543970 by U
niversity C
ollege London user on 12 August 2019
